Insider · CIK 0001705287

FLESHER GREGORY J.

Reports to the SEC for 3 companies · IRVINE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001705287

Forms 4 and 5

Insider transactions

14 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-12-09	OKUROnKure Therapeutics, Inc. · Stock option (right to buy)A Award	Director, President and CEO	AAward	+300K sh	—	—	300,000
2021-12-10	OKUROnKure Therapeutics, Inc.A Award	Director, President and CEO	AAward	+100K sh	—	—	109,600
2021-12-10	OKUROnKure Therapeutics, Inc. · Stock option (right to buy)A Award	Director, President and CEO	AAward	+200K sh	—	—	200,000
2021-08-25	OKUROnKure Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+8,000 sh	$8.00	+$64K	8,000
2020-03-19	ELDNEledon Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+200K sh	—	—	200,000
2019-09-26	ELDNEledon Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	100,000
2019-05-21	ELDNEledon Pharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,937 sh	$1.91	−$5,613.782	156,918
2019-05-20	ELDNEledon Pharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−11.7K sh	$1.96	−$23K	159,855
2019-03-14	ELDNEledon Pharmaceuticals, Inc.A Award	Director, Chief Executive Officer	AAward	+25K sh	—	—	171,556
2019-03-14	ELDNEledon Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+90K sh	—	—	90,000
2018-03-13	ELDNEledon Pharmaceuticals, Inc.A Award	Director, Chief Executive Officer	AAward	+30.7K sh	—	—	146,556
2018-03-13	ELDNEledon Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+56.5K sh	—	—	56,500
2017-05-24	ELDNEledon Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+250K sh	—	—	250,000
2017-05-10	ELDNEledon Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+59K sh	$9.99	+$589K	115,856

Recent filings

Accepted (ET)
Dec 134
FLESHER GREGORY J.0001209191-22-061034
SEC(opens sec.gov)
Dec 144
FLESHER GREGORY J.0001209191-21-069443
SEC(opens sec.gov)
Aug 264
FLESHER GREGORY J.0001209191-21-053522
SEC(opens sec.gov)
Mar 204
FLESHER GREGORY J.0000899243-20-009126
SEC(opens sec.gov)
Sep 304
FLESHER GREGORY J.0000899243-19-024431
SEC(opens sec.gov)
May 224
FLESHER GREGORY J.0001562180-19-003051
SEC(opens sec.gov)
Mar 184
FLESHER GREGORY J.0000899243-19-008140
SEC(opens sec.gov)
Mar 154
FLESHER GREGORY J.0000899243-18-007647
SEC(opens sec.gov)
May 264
Novus Therapeutics, Inc.0000899243-17-014542
SEC(opens sec.gov)
May 114
Novus Therapeutics, Inc.0000899243-17-012936
SEC(opens sec.gov)

Companies

Address

C/O NOVUS THERAPEUTICS, INC 19900 MACARTHUR BLVD., SUITE 550

IRVINE, CA, 92612